Last reviewed · How we verify

NCT06134245: HOUSE

HOme USability Evaluation

Status unknown Last updated 18 November 2023
What this trial tests

trial testing Entia Liberty in Cancer in 100 participants. Status unknown.

Timeline
1 March 2024
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorEntia Ltd
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 March 2024
Primary completion30 June 2024
Estimated completion30 June 2024

Drugs / interventions tested

Conditions studied

Sponsor

Entia Ltd

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To validate the usability and safety of the Liberty Analyser.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Entia Liberty

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Entia Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06134245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing